{"id":784545,"date":"2023-09-18T09:52:59","date_gmt":"2023-09-18T13:52:59","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/enovis-debuts-new-foot-ankle-offerings-at-the-aofas-annual-meeting\/"},"modified":"2023-09-18T09:52:59","modified_gmt":"2023-09-18T13:52:59","slug":"enovis-debuts-new-foot-ankle-offerings-at-the-aofas-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/enovis-debuts-new-foot-ankle-offerings-at-the-aofas-annual-meeting\/","title":{"rendered":"Enovis Debuts New Foot & Ankle Offerings at the AOFAS Annual Meeting"},"content":{"rendered":"

\nNew solutions in Percutaneous and Open Bunion procedures, External Fixation, and Patient Specific Instrumentation, will be featured as part of the company\u2019s growing evidence based, high tech portfolio.
\n<\/h2>\n
\n

Wilmington, DE, Sept. 18, 2023 (GLOBE NEWSWIRE) — Today, Enovis\u2122 Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase new products from its recent acquisitions of Novastep\u00ae and the external fixation assets of D.N.E., LLC, along with its new, organically developed Evolve34\u2122 Lapidus Instrumentation, and the new \u201cSTAR+ Experience,\u201d Enovis\u2019 Total Ankle System plus patient specific instrumentation (PSI), at the American Orthopaedic Foot & Ankle Society\u00ae (AOFAS) annual meeting in Louisville, Kentucky from September 20-23, 2023.<\/p>\n

\u201cEnovis\u2122 is dedicated to improving patient outcomes by introducing technologies that solve real issues in the foot and ankle industry,\u201d stated Gary Justak, President and General Manager of Enovis\u2122 Foot and Ankle. \u201cOur recent acquisition of Novastep\u00ae and the Pecaplasty\u00ae Percutaneous Bunion Correction System will drive outcome improvements with an underserved patient population, and the MIS bunion surgery provides efficiency in the OR for the surgeon, while improving patient recovery times with less pain.1,2,3\u201d<\/sup><\/p>\n

Other offerings being showcased for the first time will be Evolve34\u2122, a bunion solution for Lapidus correction that allows surgeons to dial in deformity correction and select a hardware construct specific for the patient\u2019s needs. Additionally, Enovis will be introducing the all new EF1 External Fixation product line, complimenting the flagship DynaNail\u00ae and DynaClip\u2122 offerings in the hindfoot segment.<\/p>\n

Enovis\u2122 will also highlight products from its foot and ankle continuum of care including:<\/p>\n